←Back to list

Kindbody

Vertically integrated fertility clinic network and family-building benefits provider
Healthcare 📍 New York, NY Founded 2018
Current Valuation
$1.8B
as of 2023-Q1
UNICORN

IPO Outlookprivate

Is Kindbody going public?
No. Kindbody is private and has not filed to go public. There is no S-1 on file.
What is Kindbody's valuation in 2026?
Kindbody is valued at $1.8B as of 2023-Q1, set by its Series D ($66.21M, May 2023). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Kindbody filed an S-1?
No public S-1 is on file for Kindbody.
Who are Kindbody's investors?
Kindbody's investors include Perceptive Advisors, Claritas Capital, GV, RRE Ventures, Tribe Capital.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Kindbody operates a vertically integrated network of fertility clinics combined with an employer-benefits business that contracts with Fortune 500 customers for IVF and family-building coverage. The company reached a $1.8 billion valuation in its 2023 Series D, but spent 2024 restructuring — shuttering underperforming clinics and shuffling its C-suite before founder Gina Bartasi returned as CEO. Management has since guided to $225-$250M in 2024 revenue with the business now profitable after years of losses.

Company Profile

CEO
Gina Bartasi
Founded
2018
HQ
New York, NY
Employees
~1100
Total Raised
$315M
Est. Revenue
$237.5M (2024)
Growth
Path to profitability after restructuring
Last Round
Series D — $66.21M (May 2023) · Lead: Perceptive Advisors
IPO Status
private

Fundraising Status

Series D · $66.21M · 3y 3mo ago
privateTotal raised $315M

Secondary Market

Implied price / share
$23.85
Open interest
3
Secondary price return by period
Secondary market period returns3-month+1.0%6-month+0.1%1-year+31.3%All-time-44.5%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series D$66.21MMay 2023Perceptive Advisors—

Talent Signal

Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
5
via careers page
Product-build share
100%
engineering, research, product, design
Trajectory
steady
heavy product build — 100% of open roles are product-building functions (engineering/research/product) — 5 of 5 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month5Aug '26
Open roles by function
Open roles by functionClinical & Science5
■ product-building   ■ go-to-market / G&A
Clinical ExcellencePHYSICIAN LICENSES[Clinical Excellence](https://kindbody.com/clinical-excellence/)[Clinical Excellence](https://kindbody.com/clinical-excellence/ "Clinical Excell[PHYSICIAN LICENSES](https://kindbody.com/physician-licenses/)
Counted from Kindbody's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Gina Bartasi

Investors

Perceptive Advisors · Claritas Capital · GV · RRE Ventures · Tribe Capital

Products

  • Fertility clinics (IVF, IUI, egg freezing)
  • Employer fertility benefits
  • Gynecology services
  • Mental health and wellness
  • LGBTQ+ family-building

Competitors

Progyny · Carrot Fertility · Maven Clinic · Inception Fertility · WIN Fertility
HealthcareFertilityWomen's HealthBenefits
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q1. Refreshed quarterly.